Startup that clones patient data gets $26 million from investors
Summary
MDClone has built what it says is the “first of its kind” software that allows on-demand and self-service access to healthcare data, without the need of going through mediators or waiting for permits, by creating what it calls a “synthetic data” platform, or a “data sandbox.” Get The Start-Up Israels Daily Start-Up by email and never miss our top stories Free Sign Up The software scans the original patient information in databases and then clones it, omitting the patients’ personal details. With the new funds and investor backing, “we can turn data into a real strategic asset to transform care around the world,” Ofek added. MDClone plans to further develop its software and build new products and new approaches, as well as accelerate sales and marketing efforts, the statement said. MDClone was founded in 2016 in Israel and has since expanded to the US where its current clients include Washington University School of Medicine in St. Louis, Intermountain Healthcare and the Regenstrief Institute. “MDClone is resolving one of the greatest challenges in this emerging era of health-tech: centralizing, optimizing and enabling quick and easy access to health data, while preserving privacy and compliance,” said Yair Schindel, co-founder and managing partner of aMoon.